Swine Health - PRRS
    Targeted development of neutralizing monoclonal antibodies against PRRSV minor glycoproteins
    February 26, 2021By Dr. Hiep Vu Ph.D.
       
      
    Swine Health - PRRS
    Development of a live-attenuated PRRSV vaccine capable of eliciting a broad spectrum of heterologous protection
    February 26, 2021By Hiep Vu
          
        PRRS modified live virus (MLV) vaccines have been licensed for clinical administration for over 20 years. The vaccines confer solid protection against homologous PRRSV strains. However, the extent...      
       
      
    Swine Health - PRRS
    Recombinant porcine interferon to control PRRSV and select other viral pathogens
    December 10, 2020By Bradley Blitvich
       
      
    Swine Health - PRRS
    Nanodisc-based mucosal DIVA vaccine for PRRS virus
    September 30, 2020By Federico A. Zuckermann
       
      
    Swine Health - PRRS
    Evaluation of the intranasal route of MLV vaccination for large scale applications
    May 2, 2020By Tanja Opriessnig
       
      
    Swine Health - PRRS
    Using genomic tools to link PRRSV quasispecies to disease severity in pigs infected with contemporary virulent isolates
    March 4, 2020By Montse Torremorell
       
      
    Swine Health - PRRS
    Role of the viral ovarian domain protease in PRRSV pathogenesis
    January 24, 2020By Dr. Kay S. Faaberg Ph.D.
       
      
    Swine Health - PRRS
    PRRSv detection over time in different age groups in breeding herds attempting to produce PRRSv-negative piglets at weaning: part 2: suckling pig population
    December 20, 2019By Dr. Daniel Linhares DVM
       
      
    Swine Health - PRRS
    Genetic modifications in CD163 that confer complete resistance of pigs to infection with PRRSV
    November 26, 2019By Dr. Raymond R. Rowland Ph.D.
       
      
    Swine Health - PRRS
    Characteristics of Unusually Virulent Contemporary PRRSV Isolates
    November 26, 2019By Dr. Michael P. Murtaugh Ph.D.